European Medicines Agency approves Paxlovid, Pfizer's anti-Covid pill

Steph Deschamps / January 28, 2022

The European Medicines Agency (EMA) said Thursday it has approved Pfizer's anti-Covid pill, which becomes the first orally taken antiviral drug approved in the European Union.
  
The EMA recommended authorizing Paxlovid for the treatment of Covid-19 in adults who do not require supplemental oxygen and are at increased risk of the disease becoming severe, the European regulator said in a statement.
  
With the approval of Paxlovid this week, 6 anti-Covid drugs have been approved as part of the EU therapeutic strategy, European Commissioner for Health and Food Safety Stella Kyriakides welcomed in a statement.
  
The United States, Canada and Israel are among a handful of countries that have already given the green light to Pfizer's treatment.
      HTML Image as link                              

Related Posts

Coronavirus - Omicron: patients are not seriously ill for the moment
Coronavirus - Omicron: patients are not seriously ill for the moment
Sylvie Claire / November 28, 2021 People infected in South Africa with the new variant of the Omicron coronavirus ar...
Read More
The new variant of the coronavirus classified of concern by the WHO and named Omicron
The new variant of the coronavirus classified of concern by the WHO and named Omicron
Sylvie Claire / November 27, 2021 The new variant is now called Omicron. Experts mandated by the World Health Organ...
Read More
Coronavirus: Russian Sputnik V vaccine developers claim longer efficacy
Coronavirus: Russian Sputnik V vaccine developers claim longer efficacy
Sylvie Claire / November 25, 2021   The developers of Sputnik V said Wednesday that the Russian vaccine was more effe...
Read More